Last reviewed: July 9, 2026

Last updated: July 9, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Approximately 30% of people taking GLP-1 medications experience inadequate weight loss or bothersome side effects, even at prescription doses. If Wegovy hasn't delivered the results you hoped for, personalized compounded GLP-1 therapy and genetic insights may unlock a more effective path forward. PlexusDx specializes in precision dosing and medication selection tailored to your body's unique peptide signaling.

Start your GLP-1 program with PlexusDx

One all-inclusive price covers your online provider visit, prescription, compounded medication, and shipping — no membership, no hidden fees. Complete a short intake and a licensed provider takes it from there.

Start your intake →

Why Standard GLP-1 Therapy May Not Work for Everyone

GLP-1 medications like Wegovy suppress appetite by binding to glucagon-like peptide-1 receptors in your brain and gut. However, genetic variation in your GLP1R gene (rs6923761) influences how strongly your body responds to this signal. Some people carry variants that reduce receptor sensitivity, meaning a standard dose may feel ineffective or require escalation beyond what's comfortable.

Additionally, your weight loss response depends on multiple hormone pathways—not just GLP-1. The FTO gene (rs9939609) affects hunger perception and metabolic efficiency. The MC4R variant (rs17782313) influences appetite circuits. The GIPR gene (rs1800437) plays a role in glucose-dependent insulin secretion. When these pathways work against you genetically, medication choice and dosing strategy become critical.

Real-world data shows that tirzepatide (which targets both GLP-1 and GIP receptors) produces greater weight loss than semaglutide alone in some patients—particularly those with specific genetic profiles. Knowing your peptide pathway strengths before committing to one medication can save months of trial-and-error.

Compounded GLP-1 Medications: Flexibility Beyond Wegovy

Wegovy comes as a branded, pre-filled injection in fixed-dose increments (0.25 mg, 0.5 mg, 1 mg, up to 2.4 mg weekly). PlexusDx partners with licensed 503A compounding pharmacies to create custom-dosed semaglutide and tirzepatide injections tailored to your starting point and titration pace. This flexibility means your dose can rise or fall based on your response—without your price changing. Compounded Semaglutide Injection is $189/mo month-to-month (or $149/mo on the 6-month plan), and Compounded Tirzepatide Injection is $289/mo month-to-month (or $249/mo on the 6-month plan).

For patients who struggle with injection anxiety, PlexusDx also offers oral formulations. Oral Semaglutide is $289/mo month-to-month, or from $249/mo on the 6-month plan, while Oral Tirzepatide is $349/mo month-to-month (or $279/mo on the 6-month plan). Both preserve medication efficacy while removing needle barriers. Some patients find oral options easier to integrate into daily routines, particularly when traveling or managing multiple medications.

Dual-Compound GLP-Squared: Why One Hormone Isn't Always Enough

GLP-Squared Injection combines semaglutide and tirzepatide into a single weekly shot, activating both GLP-1 and GIP pathways simultaneously. This dual-receptor approach mirrors what tirzepatide does internally, but PlexusDx can adjust the semaglutide-to-tirzepatide ratio based on your genetic profile and tolerability. GLP-Squared Injection is $289/mo month-to-month (or $249/mo on the 3-month plan), making it cost-comparable to single-compound tirzepatide while offering additional flexibility.

Patients who responded modestly to semaglutide alone or experienced plateau weight loss often see renewed progress with GLP-Squared. The synergistic effect of dual activation enhances satiety signaling and metabolic rate. For those preferring oral dosing,, while GLP-Squared Oral is $389/mo month-to-month, or from $369/mo on the 3-month planform.

The Precision Peptide Genetic Test: Decode Your Metabolic Blueprint

The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month) analyzes GLP1R, GIPR, FTO, and MC4R — variants that relate to GLP-1 and related signaling pathways. It does not predict your response to Wegovy or determine your dose; it offers pathway-level context for a conversation with your provider. Genetics is a guide, not a guarantee.

The test examines variants in GLP1R, GIPR, FTO, MC4R, and other critical genes affecting body weight. Results show whether you're a responder to GLP-1 monotherapy, a GIP-pathway amplifier who benefits from tirzepatide, or a dual-pathway candidate who needs both signals activated. PlexusDx clinicians use these insights to recommend the medication formulation (injection vs. oral), starting dose, and escalation strategy most likely to work for your genetics.

Accessibility and Affordability: No Insurance or Membership Required

PlexusDx serves all 50 states without requiring insurance approval, membership fees, or prior authorizations. Monthly pricing is flat across all commitment tiers—your dose may rise, but your cost stays the same. All medications come from licensed 503A compounding pharmacies, ensuring pharmaceutical-grade quality and safety.

PlexusDx accounts are HSA/FSA eligible, allowing you to use pre-tax health savings to cover treatment costs. This structure makes personalized GLP-1 therapy accessible regardless of insurance status or employment situation. Starting treatment is straightforward: complete a medical intake, connect with a clinician, and receive your prescription within days.

How Your Genetics Relate to GLP-1 Pathways

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — relate to the biological pathways these medications act on. These are pathway-level associations only and do not predict how much weight you will lose or how you will respond to any specific medication. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights so you and your provider can see how your genes relate to these pathways. It does not recommend, prescribe, or determine which medication, dose, or peptide is right for you. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives you and your provider pathway-level genetic context to support a more personalized conversation. Genetics is a guide, not a guarantee.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers seven prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Precision Peptide Genetic Test is $298 standalone, or $99 as an add-on to any protocol. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

How is PlexusDx compounded semaglutide different from Wegovy?

Wegovy is a branded, fixed-dose injectable. PlexusDx compounds custom-dosed semaglutide in licensed 503A pharmacies, allowing flexible titration and personalized starting points. Both contain the same active ingredient (semaglutide), but PlexusDx's approach removes dose-lock constraints and offers oral alternatives. Your dose can adjust without price increases.

What does the Precision Peptide Genetic Test actually measure?

No — the Precision Peptide Genetic Test does not predict your response to tirzepatide or any specific medication. It analyzes pathway-level variants (GLP1R, GIPR, FTO, and MC4R) that relate to the biology involved, offering context for a conversation with your provider rather than a prediction.

Can I use HSA or FSA funds to pay for PlexusDx treatment?

Yes. PlexusDx accounts and medications (including the Precision Peptide Genetic Test) are eligible for both HSA and FSA deduction. This allows you to use pre-tax healthcare savings to cover personalized GLP-1 therapy, reducing your out-of-pocket cost significantly.

Is compounded GLP-1 from PlexusDx as safe as Wegovy?

PlexusDx medications are compounded in licensed 503A pharmacies under federal oversight, using the same pharmaceutical-grade active ingredients as Wegovy. While compounded medications are not FDA-approved (unlike Wegovy), they undergo rigorous quality and potency testing. Both semaglutide and tirzepatide carry similar side effect profiles (nausea, vomiting, constipation) and contraindications.

How does genetic testing help me choose between semaglutide and tirzepatide?

If your Precision Peptide Genetic Test shows strong GIP-receptor sensitivity (GIPR rs1800437 variants) or weak GLP-1 response (GLP1R rs6923761 variants), tirzepatide—which activates both pathways—may deliver better results than semaglutide alone. Conversely, if your FTO and MC4R pathways are optimized for single-hormone therapy, compounded semaglutide may suffice at lower cost. PlexusDx clinicians interpret your results and recommend the best fit.

Related Reading

Pricing and availability current as of July 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.

Real prescribers. Published prices. No surprises.

Licensed providers in all 50 states. Online intake. No insurance, no membership required.

Start My Intake →

~60 seconds · $0 charged until your provider approves